Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
11.89
↑ 320% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
2.83
Historical baseline
PeriodValueYoY Change
202511.89+10.5%
202410.77-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-
20180.00-